M&A

News

Eisai's bid to develop an integrated care platform for dementia in Japan has moved forward with the acquisition of remote monitoring firm EcoNaviSta.

News

Two pharmas that filed for bankruptcy protection due to opioid litigation in the US – Mallinckrodt and Endo – are rumoured to be in merger talks.

News

Bristol Myers Squibb has moved to take full control of the CAR-T therapy it partners with 2seventy bio, agreeing to buy the biotech for around $286m.

News

Sun Pharma has agreed to acquire Checkpoint Therapeutics, which recently claimed FDA approval for its first drug but is also running short on cash.

News

XRHealth has made its second acquisition in the space of a few months, buying digital therapeutics (DTx) company RealizedCare.

News

Jazz has reached an agreement to buy Chimerix for around $935 million, adding a brain cancer drug heading for an FDA approval decision in August.